Titre : Années de vie ajustées sur la qualité

Années de vie ajustées sur la qualité : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunization Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Années de vie ajustées sur la qualité : Questions médicales les plus fréquentes", "headline": "Années de vie ajustées sur la qualité : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Années de vie ajustées sur la qualité : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-21", "dateModified": "2025-04-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Années de vie ajustées sur la qualité" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Espérance de vie", "url": "https://questionsmedicales.fr/mesh/D008017", "about": { "@type": "MedicalCondition", "name": "Espérance de vie", "code": { "@type": "MedicalCode", "code": "D008017", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.308.985.450" } } }, "about": { "@type": "MedicalCondition", "name": "Années de vie ajustées sur la qualité", "alternateName": "Quality-Adjusted Life Years", "code": { "@type": "MedicalCode", "code": "D019057", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Werner B F Brouwer", "url": "https://questionsmedicales.fr/author/Werner%20B%20F%20Brouwer", "affiliation": { "@type": "Organization", "name": "Erasmus School of Health Policy & Management (ESHPM), Erasmus University, Rotterdam, the Netherlands." } }, { "@type": "Person", "name": "Lei Si", "url": "https://questionsmedicales.fr/author/Lei%20Si", "affiliation": { "@type": "Organization", "name": "The George Institute for Global Health, UNSW Sydney, Kensington, Australia." } }, { "@type": "Person", "name": "Andrew J Palmer", "url": "https://questionsmedicales.fr/author/Andrew%20J%20Palmer", "affiliation": { "@type": "Organization", "name": "Menzies Institute for Medical Research, University of Tasmania, Menzies Institute for Medical Research, Hobart, Tasmania, Australia." } }, { "@type": "Person", "name": "Ziping Ye", "url": "https://questionsmedicales.fr/author/Ziping%20Ye", "affiliation": { "@type": "Organization", "name": "College of Business Administration, Shenyang Pharmaceutical University, Shenyang, 110016, China." } }, { "@type": "Person", "name": "Lihua Sun", "url": "https://questionsmedicales.fr/author/Lihua%20Sun", "affiliation": { "@type": "Organization", "name": "College of Business Administration, Shenyang Pharmaceutical University, Shenyang, 110016, China. sunlh@syphu.edu.cn." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Immunization coverage, knowledge, satisfaction, and associated factors of non-National Immunization Program vaccines among migrant and left-behind families in China: evidence from Zhejiang and Henan provinces.", "datePublished": "2023-10-13", "url": "https://questionsmedicales.fr/article/37833775", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40249-023-01145-5" } }, { "@type": "ScholarlyArticle", "name": "Indicators of the National Immunization Program for children under one year old: time trend in Maranhão, Brazil, 2010 to 2021.", "datePublished": "2023-05-15", "url": "https://questionsmedicales.fr/article/37531541", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1413-81232023288.07312023" } }, { "@type": "ScholarlyArticle", "name": "Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region.", "datePublished": "2024-06-26", "url": "https://questionsmedicales.fr/article/38925146", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2024.2362449" } }, { "@type": "ScholarlyArticle", "name": "Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo.", "datePublished": "2023-11-19", "url": "https://questionsmedicales.fr/article/37989612", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2023.11.029" } }, { "@type": "ScholarlyArticle", "name": "Post-epidemic health system recovery: A comparative case study analysis of routine immunization programs in the Republics of Haiti and Liberia.", "datePublished": "2023-10-17", "url": "https://questionsmedicales.fr/article/37847680", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0292793" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Collecte de données", "item": "https://questionsmedicales.fr/mesh/D003625" }, { "@type": "ListItem", "position": 6, "name": "Registre civil", "item": "https://questionsmedicales.fr/mesh/D014798" }, { "@type": "ListItem", "position": 7, "name": "Espérance de vie", "item": "https://questionsmedicales.fr/mesh/D008017" }, { "@type": "ListItem", "position": 8, "name": "Années de vie ajustées sur la qualité", "item": "https://questionsmedicales.fr/mesh/D019057" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Années de vie ajustées sur la qualité - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Années de vie ajustées sur la qualité", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Années de vie ajustées sur la qualité", "description": "Comment évaluer les QALY d'un patient ?\nQuels outils mesurent la qualité de vie ?\nLes QALY sont-ils utilisés en oncologie ?\nQuel rôle joue l'analyse coût-efficacité ?\nLes QALY sont-ils universels ?", "url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Années de vie ajustées sur la qualité", "description": "Quels symptômes affectent la qualité de vie ?\nComment la dépression influence les QALY ?\nLes symptômes physiques affectent-ils les QALY ?\nQuels symptômes sont évalués dans les QALY ?\nLes symptômes mentaux impactent-ils les QALY ?", "url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Années de vie ajustées sur la qualité", "description": "Comment la prévention affecte-t-elle les QALY ?\nLes vaccinations augmentent-elles les QALY ?\nQuel rôle joue l'éducation à la santé ?\nLes dépistages précoces influencent-ils les QALY ?\nComment le mode de vie impacte-t-il les QALY ?", "url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Années de vie ajustées sur la qualité", "description": "Comment les traitements influencent-ils les QALY ?\nLes interventions chirurgicales augmentent-elles les QALY ?\nLes médicaments améliorent-ils les QALY ?\nQuel est l'impact des soins palliatifs sur les QALY ?\nLes traitements préventifs influencent-ils les QALY ?", "url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Années de vie ajustées sur la qualité", "description": "Quelles complications réduisent les QALY ?\nLes complications mentales affectent-elles les QALY ?\nComment les complications cardiovasculaires influencent-elles les QALY ?\nLes complications liées au diabète impactent-elles les QALY ?\nLes complications respiratoires influencent-elles les QALY ?", "url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Années de vie ajustées sur la qualité", "description": "Quels facteurs de risque diminuent les QALY ?\nL'âge est-il un facteur de risque pour les QALY ?\nLe stress impacte-t-il les QALY ?\nLes habitudes alimentaires influencent-elles les QALY ?\nL'alcool affecte-t-il les QALY ?", "url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer les QALY d'un patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les QALY sont calculés en multipliant les années de vie par un coefficient de qualité." } }, { "@type": "Question", "name": "Quels outils mesurent la qualité de vie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires comme le EQ-5D ou le SF-36 sont utilisés pour mesurer la qualité de vie." } }, { "@type": "Question", "name": "Les QALY sont-ils utilisés en oncologie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les QALY aident à évaluer l'efficacité des traitements en oncologie." } }, { "@type": "Question", "name": "Quel rôle joue l'analyse coût-efficacité ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elle compare le coût des interventions par rapport aux QALY gagnés pour guider les décisions." } }, { "@type": "Question", "name": "Les QALY sont-ils universels ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, les valeurs de qualité de vie peuvent varier selon les cultures et les contextes." } }, { "@type": "Question", "name": "Quels symptômes affectent la qualité de vie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "La douleur chronique, la fatigue et l'anxiété impactent significativement la qualité de vie." } }, { "@type": "Question", "name": "Comment la dépression influence les QALY ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La dépression réduit la qualité de vie, diminuant ainsi les QALY d'un individu." } }, { "@type": "Question", "name": "Les symptômes physiques affectent-ils les QALY ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes physiques non traités peuvent réduire les QALY en altérant la qualité de vie." } }, { "@type": "Question", "name": "Quels symptômes sont évalués dans les QALY ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes tels que la douleur, la mobilité et l'humeur sont souvent évalués." } }, { "@type": "Question", "name": "Les symptômes mentaux impactent-ils les QALY ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles mentaux peuvent significativement diminuer les QALY en affectant la qualité de vie." } }, { "@type": "Question", "name": "Comment la prévention affecte-t-elle les QALY ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention réduit l'incidence des maladies, augmentant ainsi les QALY dans la population." } }, { "@type": "Question", "name": "Les vaccinations augmentent-elles les QALY ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations préviennent des maladies graves, augmentant les QALY." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation à la santé ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation à la santé améliore les comportements de santé, augmentant les QALY." } }, { "@type": "Question", "name": "Les dépistages précoces influencent-ils les QALY ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce permet de traiter les maladies à un stade précoce, augmentant les QALY." } }, { "@type": "Question", "name": "Comment le mode de vie impacte-t-il les QALY ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain (alimentation, exercice) améliore la qualité de vie et augmente les QALY." } }, { "@type": "Question", "name": "Comment les traitements influencent-ils les QALY ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements efficaces augmentent les QALY en améliorant la qualité et la durée de vie." } }, { "@type": "Question", "name": "Les interventions chirurgicales augmentent-elles les QALY ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les interventions chirurgicales peuvent améliorer la qualité de vie et augmenter les QALY." } }, { "@type": "Question", "name": "Les médicaments améliorent-ils les QALY ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments peuvent améliorer les QALY en soulageant les symptômes et en prolongeant la vie." } }, { "@type": "Question", "name": "Quel est l'impact des soins palliatifs sur les QALY ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les soins palliatifs visent à améliorer la qualité de vie, augmentant ainsi les QALY." } }, { "@type": "Question", "name": "Les traitements préventifs influencent-ils les QALY ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements préventifs peuvent augmenter les QALY en réduisant l'incidence des maladies." } }, { "@type": "Question", "name": "Quelles complications réduisent les QALY ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme les infections ou les comorbidités peuvent réduire les QALY." } }, { "@type": "Question", "name": "Les complications mentales affectent-elles les QALY ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications mentales comme l'anxiété peuvent diminuer les QALY en altérant la qualité de vie." } }, { "@type": "Question", "name": "Comment les complications cardiovasculaires influencent-elles les QALY ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications cardiovasculaires peuvent réduire la durée et la qualité de vie, diminuant les QALY." } }, { "@type": "Question", "name": "Les complications liées au diabète impactent-elles les QALY ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications du diabète peuvent gravement affecter la qualité de vie et réduire les QALY." } }, { "@type": "Question", "name": "Les complications respiratoires influencent-elles les QALY ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications respiratoires peuvent réduire la qualité de vie et diminuer les QALY." } }, { "@type": "Question", "name": "Quels facteurs de risque diminuent les QALY ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme le tabagisme, l'obésité et l'inactivité physique diminuent les QALY." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour les QALY ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé est souvent associé à une diminution des QALY en raison de maladies chroniques." } }, { "@type": "Question", "name": "Le stress impacte-t-il les QALY ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la qualité de vie et réduire les QALY." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les QALY ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise alimentation peut augmenter le risque de maladies, diminuant les QALY." } }, { "@type": "Question", "name": "L'alcool affecte-t-il les QALY ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation excessive d'alcool peut réduire la qualité de vie et les QALY." } } ] } ] }

Sources (10000 au total)

Immunization coverage, knowledge, satisfaction, and associated factors of non-National Immunization Program vaccines among migrant and left-behind families in China: evidence from Zhejiang and Henan provinces.

Migrant and left-behind families are vulnerable in health services utilization, but little is known about their disparities in immunization of non-National Immunization Program (NIP) vaccines. This st... A cross-sectional survey was conducted in urban areas of Zhejiang and rural areas of Henan in China. A total of 1648 caregivers of children aged 1-6 years were interviewed face-to-face by a pre-design... The immunization coverage of all non-NIP vaccines and knowledge of all items of local urban families was the highest, followed by migrant, non-left-behind and left-behind families. Compared with local... There were immunization disparities in non-NIP vaccines among migrant and left-behind families compared with their local counterparts. Non-NIP vaccination promotion strategies, including education on ...

Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region.

There is limited literature on current human papillomavirus (HPV) vaccination in the Asia-Pacific region. This integrative literature review was conducted to describe HPV vaccination programs in Hong ...

Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo.

Low immunization coverage rates in the Democratic Republic of Congo (DRC) have been reflective of challenges with vaccine access, support and delivery in the country. Motivated by measles and vaccine-... These MoUs were 5-year partnerships designed to aid provinces in meeting four key objectives: 80 % immunization coverage, management/elimination of polio/cVDPV outbreaks, improvement of vaccine access... During the MoU period, Haut-Lomami saw an increase in full immunization coverage, from 35.7 % (MICS 2018) to 88.9 % (VCS 2021-22), the highest in country. A sharp drop in percentage of zero-dose child... Ultimately, the provincial MoUs were successful in bolstering provincial autonomy and capacity building with the biggest success being a drop in zero-dose children. While not all objectives have been ...

The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study.

In China, national immunization program (NIP) vaccines benefit from robust financial support and have achieved high coverage. Non-NIP vaccines rely on fragmented funding sources, mostly out-of-pocket ... Between July and December 2023, we conducted a series of semi-structured, in-person interviews with 55 stakeholders from the Health Bureau, Centers for Disease Control and Prevention, Medical Insuranc... Non-NIP vaccine financing sources include out-of-pocket payments, government fiscal, health insurance and other external funds. These four channels differ in vaccine types covered, costs, and target p... Relying on individual payments as the main financing channel for non-NIP vaccines is unsustainable and inadequate for ensuring universal vaccine access. A concerted and synergistic approach is essenti...

Introduction of a hexavalent vaccine containing acellular pertussis into the national immunization program for infants in Peru: a cost-consequence analysis of vaccination coverage.

Infant vaccination coverage rates in Peru have declined in recent years, exacerbated by the COVID-19 pandemic. Introduction of the fully-liquid diphtheria, tetanus, and acellular pertussis (DTaP)-inac... The analysis was performed over a 5-year period on a cohort of children born in Peru in 2020 (N = 494,595). Four scenarios were considered: the pentavalent plus IPV/OPV scheme (S1); replacing the pent... The overall cost from a public health payer perspective associated with the pentavalent plus IPV/OPV vaccine scheme (S1) was estimated at $56,719,350, increasing to $61,324,263 (+ 8.1%), $59,121,545 (... Implementation of the hexavalent vaccine in Peru's National Immunization Program has a positive public health cost consequence....